icon icon
icon
icon
Ask
icon
icon

Fennec Pharmaceuticals

FENC

FENC Fennec Pharmaceuticals NASDAQ
Add to watchlist
--
At close :
--
  • Post market
    • Summary
    Financials
    News
    Filings
    Profile
    FENC Chart
    See on advanced chart >

    About

    Fennec Pharmaceuticals Inc. was originally formed as a British Columbia corporation under the name Adherex Technologies Inc. and subsequently changed its name on September 3, 2014. Fennec, together with its wholly owned subsidiaries Oxiquant, Inc....
    Read More
    • Highlight
      A company that developing Sodium Thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients
      • Industry
      Biotechnology
    • Exchange
      NASDAQ
    • Listing Date
      09/13/2017
    • Established Date
      Invalid Date
    • Full-time Employees
      29
    • Address
      PO Box 13628 68 TW Alexander Drive Fennec Pharmaceuticals Inc. Research Triangle Park NC 27709
    • Tel
      1-919-6364530
    • Website
      www.fennecpharma.com
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock